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ABSTRACT
Objective: To estimate the risk of death or severe
harm due to bone cement implantation syndrome
(BCIS) among patients undergoing hip
hemiarthroplasty for fractured neck of femur.
Setting: Hospitals providing secondary and tertiary
care throughout the National Health Service (NHS) in
England and Wales.
Participants: Cases reported to the National
Reporting and Learning System (NRLS) in which the
reporter clearly describes severe acute patient
deterioration associated with cement use in hip
hemiarthroplasty for fractured neck of femur (assessed
independently by two reviewers).
Outcome measures: Primary—number of reported
deaths, cardiac arrests and periarrests per year.
Secondary—timing of deterioration and outcome in
relation to cement insertion.
Results: Between 2005 and 2012, the NRLS received
62 reports that clearly describe death or severe harm
associated with the use of cement in hip
hemiarthroplasty for fractured neck of femur. There
was one such incident for every 2900
hemiarthroplasties for fractured neck of femur during
the period. Of the 62 reports, 41 patients died, 14 were
resuscitated from cardiac arrest and 7 from periarrest.
Most reports (55/62, 89%) describe acute deterioration
occurring during or within a few minutes of cement
insertion. The vast majority of deaths (33/41, 80%)
occurred on the operating table.
Conclusions: These reports provide narrative
evidence from England and Wales that cement use in
hip hemiarthroplasty for fractured neck of femur is
associated with instances of perioperative death or
severe harm consistent with BCIS. In 2009, the
National Patient Safety Agency publicised this issue
and encouraged the use of mitigation measures. Three-
quarters of the deaths in this study have occurred
since that alert, suggesting incomplete implementation
or effectiveness of those mitigation measures. There is
a need for stronger evidence that weighs the risks and
benefits of cement in hip hemiarthroplasty for fractured
neck of femur.
INTRODUCTION
In 2012, more than 22 000 people in the UK
had a hemiarthroplasty following fractured
neck of femur.1 In each of these operations,
the surgeon may use cement to help hold
the prosthesis in place. There is extensive
debate about the pros and cons of doing so,
and considerable international variation in
Strengths and limitations of this study
▪ The National Reporting and Learning System
(NRLS) receives data from a health service
serving 56 million people, so it is able to detect
patterns of rare but serious harm not apparent to
individual practitioners or even within formal
trials.
▪ Reports to the NRLS provide narrative accounts
of bone cement implantation syndrome (BCIS)
from first-hand witnesses, adding to the weight
of evidence that this condition exists and is
causing death and severe harm.
▪ The NRLS suffers from under-reporting, so an
estimate of BCIS incidence derived from it is
probably an underestimate and the magnitude of
this effect is difficult to assess.
▪ The NRLS is not designed to completely assess
the benefits and risks of a treatment and its alter-
natives, so this study’s findings must be consid-
ered in conjunction with other sources that
provide information on benefits associated with
cement use, and on all-cause mortality asso-
ciated with cemented and uncemented hip
hemiarthroplasty.
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this practice.2 Almost 75 000 hip fractures (proximal
femoral fractures) occur annually in the UK, with a com-
bined medical and social care cost amounting to about
£2 billion a year. The incidence of these fractures is
likely to increase. Usually hip fractures are ‘fragility’ frac-
tures caused by a fall affecting older people with pre-
existing bone pathology (osteopenia or osteoporosis).3
In 2003, the National Health Service (NHS) in
England and Wales established a patient safety incident
reporting system, called the National Reporting and
Learning System (NRLS).4 It was designed and initially
managed by an independent agency—the National
Patient Safety Agency (NPSA). Staff throughout the
NHS were, and still are, encouraged to report any unin-
tended or unexpected incident that led to patient harm,
or could have done so.5 Nine million reports have been
received until now,6 making the NRLS the largest reposi-
tory of patient safety incidents in the world.
In 2009, the NPSA became concerned about the accu-
mulation of incident reports attributing the use of
cement in hip surgery (speciﬁcally, hemiarthroplasty for
fractured neck of femur) to sudden death and severe
harm.7 These reports seemed to denote the previously
described phenomenon of bone cement implantation
syndrome (BCIS). This involves venous embolisation of
fat and marrow contents caused by instrumentation of
the femoral canal and particularly cement insertion,
leading to hypotension, hypoxia and/or cardiac arrest.
The aetiopathogenesis of BCIS is poorly understood.
Some of the proposed mechanisms involve the release
of methyl methacrylate cement monomers into the cir-
culation following high pressures generated during
cementation. Immunological mechanisms such as hista-
mine release, complement activation and endogenous
cannabinoid-mediated vasodilation at the time of
cement insertion have also been implicated.8 9
After extensive discussion with relevant professional
bodies, guidance was issued by the NPSA to the NHS.10
This drew attention to the cluster of incidents and to the
variation in international orthopaedic practice. The
guidance advised extra precautions in the use of
cement, to do with appropriate patient assessment,
anaesthetic technique and surgical technique (ﬁgure 1).
The lack of a ﬁrm direction not to use cement reﬂected
both the absence of deﬁnitive research evidence of risk
and professional opinion that doubted the numerical
importance of the problem.10
Since the national alert was issued, a number of
research reports, mostly meta-analyses of randomised
controlled trials (RCTs), have suggested that there is no
net increased risk from cement.11–14 However, increasing
numbers of patient safety incident reports from the
NHS have continued to give stark accounts of the prox-
imity of cement insertion in hip operations to sudden
death. The NRLS is a unique repository of such informa-
tion. In this study, we examine the series of incident
reports made to the NRLS on this topic and consider
the implications for clinical policy and patient safety.
METHODS
Since 2004, staff from all parts of the NHS have been
encouraged to make an incident report of any situation
in which they believe that a patient’s safety has been
compromised. A ‘patient safety incident’ is deﬁned as:
‘Any unintended or unexpected incident which could
have, or did, lead to harm for one or more patients
receiving NHS care.15 Clinical or other staff initially
report incidents to the patient safety reporting system in
the hospital or other organisation where they work.
Subsequently, the reports are anonymised through the
removal of personal identiﬁers and forwarded to the
NRLS to allow for national-level analysis. Members of
the public are also able to report incidents directly to
the NRLS through an online form. The information
ﬁelds in each incident report cover: demographic and
administrative data; the circumstances of occurrence; a
categorisation of causation; an assessment of the degree
of harm into ‘no’, ‘low’, ‘moderate’, ‘severe’ or ‘death’
and action taken or planned to investigate or prevent a
recurrence. These data are captured in a structured
reporting form. There is also a section of free text
where the reporter is asked to describe what happened
and why they think it happened. The structure of the
database has been described in detail elsewhere.16
We searched the NRLS database for reports made
between 1 January 2005 and 31 December 2012, in
which the free-text ﬁeld contained: ‘cement’ OR
((‘death on operating table’ or ‘death on table’ or ‘died
on operating table’ or ‘intraoperative death’ or ‘cardiac
arrest’ or ‘desaturation’ or ‘hypotension’ or ‘fat
embolus’ or ‘fat embolism’ or ‘collapse’) AND (‘ortho-
paedic surgery’ or ‘orthopaedic operation’ or ‘hip
surgery’ or ‘hip operation’ or ‘hip replacement’ or
‘arthroplasty’ or ‘hemiarthroplasty’ or ‘intramedul-
lary’)). This search was applied to reports classiﬁed as
‘death’, ‘severe harm’ or ‘moderate harm’ (the latter
was included because there are instances of death being
mistakenly reported as ‘moderate harm’, for example).
Data collected during the ﬁrst year of operation of the
NRLS (2004) are not used because this is regarded as a
development phase.
Two researchers (PDR and SSP) independently
assessed the free-text descriptions provided within
retrieved reports. Each reviewer assessed whether or not
the report described, as its primary purpose, an acute
patient deterioration (immediately leading to death or
not) during or shortly after the insertion of cement in
hip hemiarthroplasty for fractured neck of femur.
Inter-rater agreement between reviewers was calculated,
and differences were resolved through arbitration by a
third reviewer (LJD).
Further data were extracted from each included
report: year of report, operation type, indication for
surgery, patient age, outcome (death, cardiac arrest or
periarrest). In addition, the timing of both the acute
deterioration and the outcome were separately cate-
gorised based on the information provided in the
2 Rutter PD, Panesar SS, Darzi A, et al. BMJ Open 2014;4:e004853. doi:10.1136/bmjopen-2014-004853
Open Access
 o
n
 18 June 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2014-004853 on 12 June 2014. Downloaded from 
free-text description. If any description suggested an
alternative or major contributing cause of death, this was
recorded. Each report was also categorised as a
‘pre-NPSA alert’ (1 January 2005 to 14 September 2009)
or a ‘post-NPSA alert’ (15 September 2009 to 31
December 2012). The cut-off date, 14 September 2009,
was the implementation deadline for the NPSA alert.
Data were recorded in Microsoft Excel 2011 and ana-
lysed in Stata V.12. Signiﬁcance tests are two-tailed. This
study was part of a research programme funded at
Imperial College by NHS England to develop incident
reporting in the NHS.
RESULTS
A total of 360 reports met the search criteria and were
examined in detail. Of these, 62 were judged by the
reviewers to describe death or severe harm associated, in
the description provided by the reporter, with the use of
cement in hip hemiarthroplasty for fractured neck of
femur. Two-thirds of these (41/62, 66%) described
deaths. A further 14 described cardiac arrests from
which the patient was resuscitated, and another seven
described periarrest situations from which the patient
recovered. Inter-rater agreement was very high (k=0.962,
p<0.0001). The number of such reports generally
increased year on year during the period (ﬁgure 2).
A further 39 reports described death or severe harm
associated with the use of cement in a different hip
operation (n=12), or in a hip operation in which the
operation type or indication (or both) was not stated in
the report (n=27).
The sensitive search strategy also yielded 259 reports
that were discarded because they did not describe death
or severe harm associated with the use of cement in any
hip operation. Most described minor errors associated
with the preparation and use of cement, such as unavail-
ability of cement or poor knowledge of cement prepar-
ation. Others related to hip surgery but not to cement,
or to surgery involving other joints.
The most common descriptions were that the acute
deterioration occurred ‘during cement insertion’ (24/
62, 39%, table 1) or ‘after cement insertion’ (16/62,
26%). Including these, the great majority of descriptions
(55/62, 89%) suggested that deterioration occurred
within approximately 3 min of cementation (‘shortly
after’ in six cases, ‘during prosthesis insertion’ in two
cases, ‘within 1 min’ in three cases and ‘within 2–3 min’
in four cases). In the remainder, the deterioration
occurred later but before the end of the operation. A
representative sample of anonymised descriptions is pro-
vided in ﬁgure 3.
All of the reported cardiac arrests and periarrests
occurred immediately, on the operating table. The
Figure 1 Measures to mitigate
risk of bone cement implantation
syndrome advised by the National
Patient Safety Agency 2009 alert.
Figure 2 Deaths, cardiac arrests
and periarrests related to hip
cement among patient safety
incident reports in England and
Wales, 2005–2012.
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majority of the deaths (33/41, 80%) also occurred on
the table. In the remainder, the acute deterioration
started as described above, but the patient did not die
until later.
The reports referred to patients aged between 66 and
100 years. The median age was 88 and the mean 87 (SD
7 years). Mean age did not differ signiﬁcantly by
outcome (87.4 years among deaths, 84.5 years among
cardiac arrests, 88.5 years among periarrests, χ2=1.722,
p=0.423).
Nearly three times as many reports were made in the
39.5 months after the NPSA alert was issued than in the
56.5 months before it (46 vs 16, table 2). The increase
in reports was more marked for deaths (3.6-fold) than
for cardiac arrests (2.4-fold) and periarrests (1.3-fold).
In addition to the 62 cases already described, 39 other
reports also clearly described deterioration leading to
death, cardiac arrest or periarrest associated with
cement use during a hip operation. These were not
included in the main analysis because they did not state
that the operation described was hemiarthroplasty for
fractured neck of femur. In just under one-third of these
reports (12/39, 31%), the operation was clearly not a
hemiarthroplasty (three total hip replacements for frac-
tured neck of femur, ﬁve total hip replacements with no
indication given, four non-arthroplasty hip operations).
The majority (27/39, 69%), however, were not included
but might have related to hemiarthroplasty for fractured
neck of femur. In 11 reports, the operation was not
stated but the indication was stated as fractured neck of
femur. In the other 16 reports, neither the operation
nor the indication was speciﬁed (except to describe a
hip operation involving cement). If some or all of these
27 reports were in fact of hemiarthroplasties for frac-
tured neck of femur, this would increase the count
reported in this paper from 62 cases potentially up to
89, an increase of up to 44%.
DISCUSSION
This paper presents a series of 62 cases of deaths or
severe harm associated, in reports to the NRLS, with the
use of cement during hip surgery. These occurred in
England and Wales between 2005 and 2012. Among
these there were 41 deaths, 14 patients who suffered a
cardiac arrest but survived, and 7 who suffered a periarr-
est but survived. With a total of 180 000 hemiarthroplas-
ties for fractured neck of femur carried out in this
period, one report of death or serious harm was
received for every 2900 cases.
The value of this paper derives from the major
strength of the NRLS—that it receives reports of adverse
events from across a health service serving 56 million
people. The NRLS can therefore detect patterns of rare
but serious harm that may not be apparent to individual
practitioners or hospitals, or indeed within formal trials.
Most reports contain a free-text description of the inci-
dent. We are therefore able to present a series of cases
highly suggestive of BCIS, with the compelling descrip-
tions provided by ﬁrst-hand witnesses adding to the
weight of evidence that, though its incidence is rare, this
Table 1 Timing of acute deterioration, as described in the
free-text section of the patient safety incident reports
Deterioration described
to have occurred
Number of
reports (%)
During cement insertion 24 39
Shortly after cement insertion 6 10
After cement insertion 16 26
During prosthesis insertion 2 3
After prosthesis insertion 1 2
At closing 1 2
Within 1 min of cement insertion 3 5
2–3 min after cement insertion 4 6
4–6 min after cement insertion 3 5
7–15 min after cement insertion 2 3
Total 62 100
Figure 3 Examples of extracts
from included patient safety
incident reports.
Table 2 Patient safety incident reports involving hip
cement occurring before and after a national alert was
issued advising precautions when using cement
Outcome
Number of reports
Prealert Postalert Total
Death 9 32 41
Cardiac arrest 4 10 14
Periarrest 3 4 7
All outcomes 16 46 62
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condition exists and is causing instances of death and
severe harm.
This study has two main weaknesses. First, the NRLS
suffers from under-reporting. The number of cases of
BCIS presented here probably under-represents its true
incidence, and the magnitude of this effect is difﬁcult to
assess. Second, the NRLS is not designed to offer a com-
plete assessment of the beneﬁts and risks of a treatment
and its alternatives. Our ﬁndings need to be considered
in conjunction with other sources that can provide infor-
mation on the beneﬁts associated with cement, and on
all-cause mortality associated with cemented and unce-
mented surgery.
The accumulation of these reports earlier led to con-
siderable concern at the NPSA, which in 2009 issued an
alert to the NHS about the issue. This alert advised
anaesthetic and surgical measures to mitigate the risk of
BCIS, rather than advising that cement should not be
used. This was despite the fact that uncemented pros-
theses are the norm in some countries, and also because
there was a lack of professional consensus in England
and Wales on the research evidence of risk and on the
size of the problem.
Since the NPSA alert was issued, a number of
meta-analyses have pooled RCT data to compare mortal-
ity between cemented and uncemented hemiarthro-
plasty in the treatment of hip fracture.11–14 These
meta-analyses are severely limited by their small size. By
our calculation, even the largest of them,12 with data
from just 1175 participants, only had sufﬁcient statistical
power to detect a mortality difference if hip cement was
causing one additional death for every 25 patients
treated (based on standard power calculation variables
α=0.1 and β=0.8, and mortality among the uncemented
group of 6%). To detect even a difference of 1 add-
itional death per 100 patients would require a 15 000
participant study. It should therefore come as no sur-
prise that none of these meta-analyses has found a statis-
tically signiﬁcant mortality difference, but this does not
demonstrate that there is no clinically signiﬁcant differ-
ence. In our view, these studies have been widely taken
to be more conclusive than they actually are.
A number of countries have well-established joint
replacement registries. Their substantial size makes
these a potentially useful source of data to address ques-
tions such as this. However, the National Joint Registry
for England, Wales and Northern Ireland17 collects data
on total hip replacement only, not on the hemiarthro-
plasties with which most of the deaths described here
are associated.
Analysis of 25 000 hemiarthroplasties recorded in the
Australian registry found that cement use was associated
with a higher mortality rate at 1 day postoperatively, but
the reverse was found at 1 week, 1 month and 1 year.18
Conversely, an analysis of the UK National Hip Fracture
Database found use of cement to be associated with a
small but signiﬁcant adjusted survival beneﬁt (adjusted
OR 0.83, 95% CI 0.72 to 0.96).19 This was based on data
from 16 496 cases in 129 hospitals over the course of a
year. It captures all causes of in-hospital mortality, and
the result is adjusted for gender, age, type of surgery
and ability to walk outdoors unaccompanied. However,
the authors admit ‘concern about the “completeness” of
the data submitted to the database: the ﬁgures are
improving, but few hospitals submit data on all their
patients with a fracture of the proximal femur’. In such
circumstances, it seems very reasonable to suppose that
patients who die intraoperatively might be less likely to
have their data submitted than patients who do not. If
so, this bias means that cases of BCIS-related death may
have been missed and the risks associated with cement
use underestimated.
The most recent registry-based analysis comes from
Norway.20 Based on 11 000 patients, it ﬁnds cement use
to be associated with a substantially higher mortality rate
within the ﬁrst day postoperatively—1 additional death
per 116 operations among cemented than uncemented
arthroplasties. This analysis is able to adjust for under-
lying differences between groups, but it suffers from
some degree of missing data.
The registries are likely to provide further valuable
information on this question, but because they allow
observational, rather than randomised, studies, it will be
vital to remove potential reporting biases and to collect
sufﬁcient information to allow for case-mix adjustment.
The patient safety incident reports detailed in this
paper are compelling, representing eyewitness accounts
of instances in which bone cement seems to have caused
death or severe harm. The NRLS and patient reporting
systems, in general, are relatively new. Such systems offer
a unique source of learning from errors at the local,
national or international level.21 There is no consensus
about how their data should be weighed alongside estab-
lished sources. For example, the current National
Institute for Health and Clinical Excellence (NICE) hip
fracture guideline22 cites the small meta-analyses and
RCTs referred to above, states that there is no evidence
of mortality difference, and so recommends the use of
cement. It takes no account of NRLS data, or indeed of
registry-based studies. Patient safety incident reports
tend to be undervalued, mainly because there is under-
reporting, but this is only likely to underestimate the
extent of a problem, not to overstate it. Such reporting
systems may by the only source powerful enough to pick
up a ‘signal’ when there is a rare cause of harm.
Even allowing for under-reporting, the data presented
here suggest that BCIS is a rare event. It might well be
the case that cement provides a beneﬁt to patients that
outweighs the harm of BCIS. For example, individual
studies have associated uncemented hip hemiarthro-
plasty with a greater number of mechanical complica-
tions23 and reoperations,24 and a decline in this
technique has been noticed in some countries.25
However, it is not straightforward to assert that cement
provides greater beneﬁt than uncemented replacement.
The considerable international variation in the use of
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cement illustrates this uncertainty. The recent NICE
guideline on hip fracture ﬁnds that the evidence on this
question is of low or moderate quality. It concludes that
cement use has a statistically signiﬁcant beneﬁt in terms
of mobility and pain, but that the scale of this beneﬁt is
not clinically signiﬁcant.
Three-quarters of the cases in this study have occurred
since the NPSA issued its 2009 alert, advising surgical
and anaesthetic measures to mitigate the risk of BCIS.10
The fact that the reported numbers have increased does
not necessarily mean that the true mortality rate has
increased. The 2009 alert advised that all cases of death
and severe harm associated with cement should be
reported. Also, since 2010, it has been compulsory in
the NHS to report any death associated with a patient
safety concern, whereas this was previously voluntary.
Further, the number of reports received by the NRLS on
all participants has increased year on year. The fact that
deaths have continued clearly shows that the implemen-
tation of mitigation measures set out in the alert was
suboptimal, or that their effectiveness is suboptimal, or
both. Patient safety incident reporting systems have been
criticised for weaknesses in cascading their learning to
frontline staff,26 and it is unclear what effect national
patient safety alerts have on the delivery of safer care.27
This study suggests that BCIS continues to cause rare
instances of death and severe harm in emergency hip
hemiarthroplasty surgery in England and Wales, despite
a 2009 national alert that advised on best practice mea-
sures to mitigate this risk. This study should serve to
reinforce the importance of taking the anaesthetic and
surgical measures known to mitigate the risk of BCIS.
This study suggests that the risk is one death or severe
harm per 2900 cases, although this conclusion is limited
by under-reporting. Although rare, BCIS contributes to
the total mortality associated with cemented hip hemiar-
throplasty surgery. To provide a deﬁnitive answer to the
question of whether cement causes net beneﬁt or net
harm, there is a need for registry-based studies that
achieve complete ascertainment of cases and gather suf-
ﬁcient information to enable the case-mix to be adjusted
for (which the currently available registry-based studies
do not), or for multicentre, expertise-based randomised
trials that are sufﬁciently powered to detect clinically
important differences in mortality rate (which the cur-
rently available meta-analyses of RCTs are not).28
More generally, this study demonstrates the value of
patient safety incident reports in examining causes of
harm that may not be detected even by studies high
within the hierarchy of traditional research evidence.
There is a need for more work on how data from studies
such as this one should be considered in tandem with
the ﬁndings of more traditional studies to optimally
answer complex patient safety questions.
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